Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00953017 · ClinicalTrials.gov registry record · Phase 4
A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy
A Phase 4 study of Colonoscopy, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 425
- Enrollment target
- 1
- Study location
NCT00953017: Completed Phase 4 study of Colonoscopy, sponsored by Brooke Army Medical Center.
NCT00953017 is a Phase 4 study of Colonoscopy that has completed, run by Brooke Army Medical Center. The registered enrollment target is 425 participants, below the 480-participant average among 20 other Colonoscopy trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00953017, a Phase 4 study of Colonoscopy, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 425 participants
- Enrollment target
- 1
- Study location
Study Summary
Miralax (PEG 3350) has been shown to be a safe and uncomplicated bowel preparation prior to colonoscopy in pediatric populations. This study seeks to confirm the efficacy of this bowel cleansing regimen in adults and to determine the benefit of adding a pretreatment medication to this bowel preparation. The tolerability of Miralax will hopefully improve patient satisfaction with colonoscopy and decrease their reluctance to be screened because of the uncomfortable taste and side effects of bowel preparation regimens.
Primary Outcome
Bowel cleansing was evaluated with the Ottawa bowel preparation scale by each endoscopist during the endoscopy. Neither the endoscopist nor the endoscopy nurse was aware of the bowel preparation used prior to the colonoscopy. The Ottawa bowel preparation scale is a validated tool and was used in this study to provide a reliable quality assessment of the bowel preparation used for colonoscopy. This validated scale rates each section of the colon, the right, the mid, and the rectosigmoid colon, on
Conditions Studied
Interventions
- DRUG Miralax (PEG 3350)
- DRUG Amitiza (Lubiprostone)
- DRUG Dulcolax (Bisacodyl)
- DRUG Golytely (polyethylene glycol)
Study Locations (1)
Texas
- Brooke Army Medical Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 425 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
What the finished NCT00953017 record still lists
NCT00953017 is an interventional study that assigns participants to a tested intervention. The registered 425 participants enrollment target is mid-sized for trials with a published cap, below the 480-participant average among 20 other Colonoscopy trials with a reported enrollment target (11% lower).
The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 4 interventions - of which Miralax (PEG 3350) is the first listed.
NCT00953017 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00953017 about?
NCT00953017 is a clinical study titled "A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy". Miralax (PEG 3350) has been shown to be a safe and uncomplicated bowel preparation prior to colonoscopy in pediatric populations. This study seeks to confirm the efficacy of this bowel cleansing regimen in adults and to determine the benefit of adding a pretreatment medication to this bowel preparat...
What is the current status of trial NCT00953017?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 425 participants. The study started on 2009-07. Estimated completion is 2010-05.
What conditions does trial NCT00953017 study?
This clinical trial studies the following conditions: Colonoscopy.
What interventions are being tested in trial NCT00953017?
The interventions under investigation include: Miralax (PEG 3350) (DRUG), Amitiza (Lubiprostone) (DRUG), Dulcolax (Bisacodyl) (DRUG), Golytely (polyethylene glycol) (DRUG).
Who is sponsoring clinical trial NCT00953017?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00953017 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00953017's enrollment target sits among peer trials
425 9th of 20 higher than 12 of 20 other Colonoscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonoscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
-
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
RECRUITING
-
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
RECRUITING · NA
-
Cold Snare Endoscopic Mucosal Resection Trial
ACTIVE NOT RECRUITING · NA
-
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05321368 · 425 participants · NA
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
- NCT05340738 · 425 participants · NA
AI-Based Fidelity Feedback to Enhance CBT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia